Deng et al. have engineered an NDDS for HCC by conjugating GPC3-targeting enzymes with Fe3O4–glucose oxidase to create Fe3O4–glucose oxidase (GOD) ––GPC3 nanoparticle peptides (FGP NPs). The gene discussed is GPC3; the disease is hepatocellular carcinoma.